{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:59:23Z","timestamp":1773842363930,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Italian Ministry of Health","award":["GR-2010-2318367"],"award-info":[{"award-number":["GR-2010-2318367"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13014-016-0586-x","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T19:17:40Z","timestamp":1453403860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["[18F]Choline PET\/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results"],"prefix":"10.1186","volume":"11","author":[{"given":"Francesco","family":"Pasqualetti","sequence":"first","affiliation":[]},{"given":"Marco","family":"Panichi","sequence":"additional","affiliation":[]},{"given":"Aldo","family":"Sainato","sequence":"additional","affiliation":[]},{"given":"Fabrizio","family":"Matteucci","sequence":"additional","affiliation":[]},{"given":"Luca","family":"Galli","sequence":"additional","affiliation":[]},{"given":"Paola","family":"Cocuzza","sequence":"additional","affiliation":[]},{"given":"Patrizia","family":"Ferrazza","sequence":"additional","affiliation":[]},{"given":"Gabriele","family":"Coraggio","sequence":"additional","affiliation":[]},{"given":"Giuseppe","family":"Pasqualetti","sequence":"additional","affiliation":[]},{"given":"Lisa","family":"Derosa","sequence":"additional","affiliation":[]},{"given":"Martina","family":"Sollini","sequence":"additional","affiliation":[]},{"given":"Lorenzo","family":"Mannelli","sequence":"additional","affiliation":[]},{"given":"Simona","family":"Ortori","sequence":"additional","affiliation":[]},{"given":"Fabio","family":"Monzani","sequence":"additional","affiliation":[]},{"given":"Sergio","family":"Ricci","sequence":"additional","affiliation":[]},{"given":"Carlo","family":"Greco","sequence":"additional","affiliation":[]},{"given":"Maria Grazia","family":"Fabrini","sequence":"additional","affiliation":[]},{"given":"Paola Anna","family":"Erba","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"issue":"2","key":"586_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"586_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"586_CR3","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374\u2013403. Research Support, Non-U.S. Gov\u2019t.","journal-title":"Eur J Cancer"},{"issue":"2","key":"586_CR4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467\u201379. Practice Guideline Review.","journal-title":"Eur Urol"},{"issue":"3","key":"586_CR5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.ju.0000113794.34810.d0","volume":"171","author":"JW Moul","year":"2004","unstructured":"Moul JW, Wu H, Sun L, McLeod DG, Amling C, Donahue T, et al. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol. 2004;171(3):1141\u20137. Comparative Study Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, Non-P.H.S.","journal-title":"J Urol"},{"issue":"3","key":"586_CR6","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.juro.2010.04.084","volume":"184","author":"G Giovacchini","year":"2010","unstructured":"Giovacchini G, Picchio M, Briganti A, Cozzarini C, Scattoni V, Salonia A, et al. [11C]choline positron emission tomography\/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. J Urol. 2010;184(3):938\u201343.","journal-title":"J Urol"},{"issue":"2","key":"586_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-009-1253-3","volume":"37","author":"G Giovacchini","year":"2010","unstructured":"Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V, et al. Predictive factors of [(11)C]choline PET\/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010;37(2):301\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"586_CR8","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/j.ejrad.2012.04.027","volume":"81","author":"C Fuccio","year":"2012","unstructured":"Fuccio C, Castellucci P, Schiavina R, Guidalotti PL, Gavaruzzi G, Montini GC, et al. Role of 11C-choline PET\/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy. Eur J Radiol. 2012;81(8):e893\u20136.","journal-title":"Eur J Radiol"},{"issue":"1","key":"586_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8\u201310. Editorial.","journal-title":"J Clin Oncol"},{"issue":"1","key":"586_CR10","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","volume":"14","author":"AC Tree","year":"2013","unstructured":"Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA, et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol. 2013;14(1):e28\u201337. Research Support, Non-U.S. Gov\u2019t Review.","journal-title":"Lancet Oncol"},{"key":"586_CR11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13014-014-0258-7","volume":"9","author":"AJ Conde Moreno","year":"2014","unstructured":"Conde Moreno AJ, Ferrer Albiach C, Muelas Soria R, Gonzalez Vidal V, Garcia Gomez R, Albert Antequera M. Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options. Radiat Oncol. 2014;9:258. Research Support, Non-U.S. Gov\u2019t.","journal-title":"Radiat Oncol"},{"issue":"1","key":"586_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clgc.2012.08.003","volume":"11","author":"P Berkovic","year":"2013","unstructured":"Berkovic P, De Meerleer G, Delrue L, Lambert B, Fonteyne V, Lumen N, et al. Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy. Clin Genitourin Cancer. 2013;11(1):27\u201332.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"586_CR13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","volume":"60","author":"P Rigatti","year":"2011","unstructured":"Rigatti P, Suardi N, Briganti A, Da Pozzo LF, Tutolo M, Villa L, et al. Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography\/computed tomography. Eur Urol. 2011;60(5):935\u201343.","journal-title":"Eur Urol"},{"key":"586_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1748-717X-9-135","volume":"9","author":"K Decaestecker","year":"2014","unstructured":"Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T, et al. Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence. Radiat Oncol. 2014;9:135.","journal-title":"Radiat Oncol"},{"issue":"5","key":"586_CR15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.eururo.2014.09.004","volume":"67","author":"P Ost","year":"2015","unstructured":"Ost P, Bossi A, Decaestecker K, De Meerleer G, Giannarini G, Karnes RJ, et al. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: A systematic review of the literature. Eur Urol. 2015;67(5):852\u201363. Review.","journal-title":"Eur Urol"},{"issue":"5","key":"586_CR16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","volume":"36","author":"KA Ahmed","year":"2013","unstructured":"Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, et al. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013;36(5):509\u201313.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"586_CR17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2009.12.038","volume":"79","author":"C Greco","year":"2011","unstructured":"Greco C, Zelefsky MJ, Lovelock M, Fuks Z, Hunt M, Rosenzweig K, et al. Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys. 2011;79(4):1151\u20137. Clinical Trial, Phase I.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"586_CR18","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ijrobp.2011.02.040","volume":"82","author":"MJ Zelefsky","year":"2012","unstructured":"Zelefsky MJ, Greco C, Motzer R, Magsanoc JM, Pei X, Lovelock M, et al. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1744\u20138. Clinical Trial, Phase I.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"586_CR19","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(14)70380-8","volume":"16","author":"MK Wilson","year":"2015","unstructured":"Wilson MK, Collyar D, Chingos DT, Friedlander M, Ho TW, Karakasis K, et al. Outcomes and endpoints in cancer trials: bridging the divide. Lancet Oncol. 2015;16(1):e43\u201352. Review.","journal-title":"Lancet Oncol"},{"issue":"1","key":"586_CR20","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(14)70375-4","volume":"16","author":"MK Wilson","year":"2015","unstructured":"Wilson MK, Karakasis K, Oza AM. Outcomes and endpoints in trials of cancer treatment: the past, present, and future. Lancet Oncol. 2015;16(1):e32\u201342. Historical Article Review.","journal-title":"Lancet Oncol"},{"issue":"11","key":"586_CR21","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/annonc\/mdt335","volume":"24","author":"MT Schweizer","year":"2013","unstructured":"Schweizer MT, Zhou XC, Wang H, Yang T, Shaukat F, Partin AW, et al. Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy. Ann Oncol. 2013;24(11):2881\u20136. Clinical Trial Research Support, N.I.H., Extramural.","journal-title":"Ann Oncol"},{"issue":"8","key":"586_CR22","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078\u2013101.","journal-title":"Med Phys"},{"issue":"9747","key":"586_CR23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","volume":"376","author":"JS Bono de","year":"2010","unstructured":"de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet. 2010;376(9747):1147\u201354. Clinical Trial, Phase III Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov\u2019t.","journal-title":"Lancet"},{"issue":"15","key":"586_CR24","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","volume":"351","author":"IF Tannock","year":"2004","unstructured":"Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351(15):1502\u201312. Clinical Trial Clinical Trial, Phase III Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov\u2019t.","journal-title":"N Engl J Med"},{"issue":"5","key":"586_CR25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.eururo.2012.08.003","volume":"63","author":"D Tilki","year":"2013","unstructured":"Tilki D, Reich O, Graser A, Hacker M, Silchinger J, Becker AJ, et al. 18F-Fluoroethylcholine PET\/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent. Eur Urol. 2013;63(5):792\u20136. Evaluation Studies.","journal-title":"Eur Urol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-016-0586-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:15:11Z","timestamp":1498263311000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ro-journal.com\/content\/11\/1\/9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1186\/s13014-016-0586-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]},"article-number":"9"}}